Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Pets at Home jumps on Betaville takeover speculation

(Sharecast News) - Pets at Home surged on Wednesday after markets blog Betaville suggested the company was at the centre of takeover rumours. Betaville said that people following the situation had heard rumours Pets at Home may have attracted takeover interest, possibly from a private equity firm.

Some people suggested the private equity firm may be based in Europe but have a similar business in the US.

Financial News pointed to the fact that "Pug Bidco Limited" and a series of related companies were registered with Companies House on 24 February.

It said the bidcos share an address with BC Partners - 40 Portman Square - and their director shares a name with BC Partners' New York-based co-head of healthcare Michael Chang.

BC Partners is the owner of US pet retailer PetSmart; Chang is involved in that investment according to his profile on the private equity firm's website.

A person close to BC Partners told Financial News that it was not true the bidcos were targeted at Pets at Home.

The shares closed up 7.8% at 248.40p, having hit as high as 270p earlier in the session.

Danni Hewson, head of financial analysis at AJ Bell, said: "Is there any bite to match all the barking that's propelled Pets at Home to the top of the FTSE 250 gainers? Shares in the company hit a three-month high after markets blog Betaville reported on rumours that the company had attracted the attention of private equity.

"Post-pandemic the company's share price was riding high, with plenty of new pet owners prepared to splash out on expensive food, toys and even outfits to spoil their new family members. But the cost-of-living crisis put consumers under pressure and, along with many retailers, Pets at Home found this past 'golden quarter' was looking a little tarnished as in-store sales were soft even if the vet business was proving resilient.

"It's this kind of softening that can provide an opportunity for an investor to bag a bargain, especially if they've already got knowledge of the sector.

"Though there remain questions over whether this is more than just a shaggy dog story and if the coming days will shed light rather than fur."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.